Myriad Genetics buy Piper Sandler
Start price
11.11.25
/
50%
€5.70
Target price
11.11.26
€7.36
Performance (%)
-26.32%
Price
17.04.26
€4.20
Summary
This prediction is currently active. The price of Myriad Genetics has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.32%. This prediction currently runs until 11.11.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | 14.754% | 14.754% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by Piper_Sandler for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics (NASDAQ:MYGN) had its price target lowered by analysts at Piper Sandler from $9.00 to $8.50. They now have an "overweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat

